Phase II Trial of E7386 in Endometrial Cancer and Establishment of Clinical Proof of Concept
A standalone development program for E7386, advancing a Phase II trial in endometrial cancer in combination with Lenvima, with the aim of establishing clinical proof of concept through response rates and dose optimization.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.